Skip to main content
. Author manuscript; available in PMC: 2008 Mar 3.
Published in final edited form as: J Neurocytol. 2005 Mar;34(1-2):117–122. doi: 10.1007/s11068-005-5051-y

Figure 1.

Figure 1

Dual-label immunocytochemistry was used to identify SCCs (anti-α-gustducin = red) and cells which incorporated BrdU (anti-BrdU = green). At early survival times, most BrdU immunoreactive cells were located along the basal lamina. At later times, both basal cells and cells higher in the epithelium were labeled with BrdU (6 day survival shown above).